Content Review 766-337324-672e7c5d2ded - OKAVA

Our Vision
Products & Science
News & Insights
About Us
Investors

Our Vision
Products & Science
News & Insights
About Us
Investors

OKAVA-site-identity-light

San Francisco, CA

Linkedin-in Instagram

About Us

Meet Our Team / Our Vision / Media Coverage

Products

Human to Pet Pipeline / OKV-119 / OKV-1001 / Publications

For vets

Medicine in Development / Participate in a Study / Our Science Library

For Pet Parents

Our Vision for Pet Health / Conditions We Treat / How We Leverage Human Medicines for Pets

Investors

Pet health market / Corporate Deck / Advantages over human BioPharma

Contact Us

General Inquiries / Investors / Press Contact

News & Insights

Content Review 766-337324-672e7c5d2ded

October 6, 2026
1:08 pm

Content review 766-337324-672e7c5d2ded link

PrevPreviousDigital Marketing Trends That Still Matter in 2026

Bringing human medical breakthroughs to pets because every pet deserves a longer, healthier life.

Join Our Studies

San Francisco, CA

Linkedin-in Instagram

Follow Our News & Announcements

Email

Copyright © 2026 Okava Pharmaceuticals. All rights reserved.

Privacy Policy
Terms & Conditions

Privacy Policy
Terms & Conditions